Graham Collins, Associate Professor, Haematology and Lymphoma Specialist at Oxford Cancer and Haematology Centre, shared a post on X:
“Herrera et al – ctDNA in S1826
• 97% ctDNA + baseline
• clearance at C3D1 associated with PFS
• within pos patients, those with minor associated with esp poor outcomes
• EOT ctDNA detection also associated with poor outcomes CtDNA ripe for response adapted trials.”
More posts featuring Graham Collins on OncoDaily.
